Glioma diagnosis is grave news for Sen. Kennedy

By Maggie Fox, Health and Science Editor

WASHINGTON (Reuters) - A diagnosis of malignant glioma is grave news for Massachusetts Sen. Edward Kennedy, brain experts said on Tuesday.

A malignant glioma kills half its victims within a year and patients rarely survive more than three years. Even surgery cannot cure such a tumor, which sends fingers of cancerous cells into nooks and crannies of the brain, doctors agreed.

However, Kennedy, 76, has a chance of extending his life with chemotherapy -- the preferred drug is a pill with few side-effects -- and radiation.

"A diagnosis of a malignant brain tumor can be one of the most terrifying diagnoses that patients or their loved ones can hear," said Dr. Keith Black, chairman of the department of neurosurgery at Cedars-Sinai Medical Center in Los Angeles.

Kennedy suffered a seizure on Saturday and has been undergoing tests in the hospital ever since. A biopsy -- a little sample of brain tissue -- confirmed a malignant glioma.

"Glioma is not a specific type of cancer. It is a general category of brain tumor that includes astrocytomas, oligodendrogliomas, and ependymomas. About 42 percent of all brain tumors, including benign ones, are gliomas," the American Cancer Society said in a statement.

But several neuro-oncologists said if the tumor is malignant, it is very likely to be one of two types -- an anaplastic astrocytoma or a glioblastoma multiforme.

"Anaplastic astrocytoma is a better prognosis," said Dr. Lynne Taylor, a spokeswoman for the American Academy of Neurology and a neuro-oncologist at the University of Washington in Seattle.